COVID-19

Young, Indian, unvaccinated: The world’s largest inoculation drive falters

Reuters

This is AI generated summarization, which may have errors. For context, always refer to the full article.

Young, Indian, unvaccinated: The world’s largest inoculation drive falters

QUEUE. People wearing protective face masks wait to receive a dose of COVISHIELD, a COVID-19 vaccine manufactured by Serum Institute of India, at a vaccination center in New Delhi, India, on May 4, 2021.

Adnan Abidi/Reuters

As of June 4, India has provided at least one dose to roughly 50 million people aged between 18 and 44, representing just 8% of that population group

India began an inoculation drive for its 1.38 billion people in earnest in mid-January.

Healthcare, frontline workers and the elderly were the first eligible, followed by people aged over 45 in April and then adults aged 18-45 in May.

That last extension, covering around 43% of the population, proved to be a crunch point.

Following a surge in COVID-19 infections across the country in April, Prime Minister Narendra Modi accelerated plans to broaden the program and opened up vaccinations from May 1 for people aged between 18 and 45 years.

The decision led to a rush by people in that age group, who account for 600 million of the population, to sign up to the government’s CoWIN vaccination website. Critically, there was no corresponding increase in vaccine supplies.

By June 4, India had provided at least one dose to roughly 50 million people aged between 18 and 44, representing just 8% of that population group.

Adding to the difficulties, a privilege gap emerged in the vaccination rollout, with hospitals charging different prices for the same vaccine. Some hospitals in affluent areas have sold the Covishield shot, manufactured in India, for 1,800 rupees ($25) a dose, almost double the 950 rupees charged elsewhere.

Also, urban Indians have received shots faster than those living in the countryside. That means vaccines remain unavailable to a large part of the population that cannot afford it or has little or no access to private hospitals.

Vaccine importer

India – the world’s biggest producer of vaccines for polio, diphtheria and other diseases – sold or donated more than 66 million COVID-19 vaccine shots to 95 countries until the middle of April.

But as infections started rising from around mid-March in India, the clamor for vaccines at home also increased. India has now started importing vaccines and also expecting donations from the United States.

The government expects vaccine supplies to improve substantially from June. It is expecting to produce enough shots by December to inoculate all of its estimated 950 million adults, though those between 18 and 45 years will be the last on the priority list.

Several states in India have begun to gradually lift restrictions on travel and businesses, after a fall in cases in recent weeks. However, health experts have warned that cases could surge again once most states reopen, and have called for vaccinations to be sped up.

As of June 8, less than 4% of India’s adult population had been given the required two vaccine doses. Nearly 14% received at least one dose and, of that group, less than one-tenth of 18-45 year olds have been inoculated. – Rappler.com

Add a comment

Sort by

There are no comments yet. Add your comment to start the conversation.

Summarize this article with AI

How does this make you feel?

Loading
Download the Rappler App!